BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

CLDI

Calidi Biotherapeutics, Inc.
NYSE · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

$0
$1$0
Q4 ’22
Company filings · 10-K filed 15 Mar 2024 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$4M−22.9% year on year
$15M$10M$5M$0
Q4 ’21Q1 ’23Q1 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com
Chart 05 is empty
Chart 06 is empty